D.S.R. Sarma

2.0k total citations
61 papers, 1.7k citations indexed

About

D.S.R. Sarma is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, D.S.R. Sarma has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in D.S.R. Sarma's work include Drug Transport and Resistance Mechanisms (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Liver physiology and pathology (8 papers). D.S.R. Sarma is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Liver physiology and pathology (8 papers). D.S.R. Sarma collaborates with scholars based in Canada, Italy and United States. D.S.R. Sarma's co-authors include Herschel Sidransky, S. Rajalakshmi, Prema M. Rao, E. Verney, Amedeo Columbano, Thomas Ying, Emmanuel Farber, Ethel Verney, Ezio Laconi and Ernest G. Seidman and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

D.S.R. Sarma

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.S.R. Sarma Canada 24 813 351 269 199 191 61 1.7k
Saúl Villa‐Treviño Mexico 26 1.1k 1.3× 312 0.9× 158 0.6× 280 1.4× 199 1.0× 102 2.2k
Henryk Taper Belgium 30 998 1.2× 207 0.6× 224 0.8× 252 1.3× 115 0.6× 68 2.3k
H Taper Belgium 21 662 0.8× 162 0.5× 282 1.0× 170 0.9× 46 0.2× 55 1.5k
Fang Sun United States 25 1.1k 1.4× 397 1.1× 132 0.5× 242 1.2× 95 0.5× 46 2.1k
C.J. Bos Netherlands 23 1.2k 1.4× 131 0.4× 314 1.2× 172 0.9× 284 1.5× 57 2.1k
Alan Warbritton United States 22 491 0.6× 224 0.6× 181 0.7× 205 1.0× 173 0.9× 47 1.9k
Kiyomi Sato Japan 29 2.7k 3.3× 517 1.5× 450 1.7× 204 1.0× 129 0.7× 82 3.5k
Yukiya Sakamoto Japan 22 1.0k 1.3× 146 0.4× 228 0.8× 115 0.6× 200 1.0× 138 2.2k
Mariette Robbi Belgium 15 1.3k 1.6× 113 0.3× 288 1.1× 124 0.6× 289 1.5× 22 2.1k
Andrew F.G. Slater Sweden 14 1.0k 1.3× 180 0.5× 280 1.0× 161 0.8× 109 0.6× 15 2.1k

Countries citing papers authored by D.S.R. Sarma

Since Specialization
Citations

This map shows the geographic impact of D.S.R. Sarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.S.R. Sarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.S.R. Sarma more than expected).

Fields of papers citing papers by D.S.R. Sarma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.S.R. Sarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.S.R. Sarma. The network helps show where D.S.R. Sarma may publish in the future.

Co-authorship network of co-authors of D.S.R. Sarma

This figure shows the co-authorship network connecting the top 25 collaborators of D.S.R. Sarma. A scholar is included among the top collaborators of D.S.R. Sarma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.S.R. Sarma. D.S.R. Sarma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Marie‐Josée, Serge Dionne, George Marx, et al.. (2009). In vitro studies on the inhibition of colon cancer by butyrate and carnitine. Nutrition. 25(11-12). 1193–1201. 57 indexed citations
2.
Ruemmele, Frank M., et al.. (1999). Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death and Differentiation. 6(8). 729–735. 102 indexed citations
3.
Laconi, Ezio, Prema M. Rao, S. Rajalakshmi, et al.. (1998). Cycloheximide sensitivity of orotic acid biosynthesis induced by ammonia and glycine administration. European Journal of Biochemistry. 251(3). 597–604. 2 indexed citations
4.
Laconi, Ezio, Sergio Laconi, Prema M. Rao, et al.. (1997). Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. Journal of Hepatology. 26(1). 203–208. 2 indexed citations
5.
Moreno, Fernando, Sharmila Manjeshwar, Ravindra Nath, et al.. (1995). Effect of β-carotene on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat liver. Cancer Letters. 96(2). 201–208. 31 indexed citations
6.
Laconi, Ezio, et al.. (1994). An earlier proliferative response of hepatocytes in γ-glutamyl transferase positive foci to partial hepatectomy. Cancer Letters. 81(2). 229–235. 2 indexed citations
8.
Manjeshwar, Sharmila, Ezio Laconi, Prema M. Rao, S. Rajalakshmi, & D.S.R. Sarma. (1993). Influence of Orotic Acid on Multistage Hepatocarcinogenesis in the Rat: Resistance of Hepatocytes from Nodules to the Mitoinhibitory Effects of Orotic Acid. Experimental Biology and Medicine. 202(1). 25–29. 6 indexed citations
9.
Laconi, Ezio, Ayumi Denda, Prema M. Rao, et al.. (1993). Studies on liver tumor promotion in the rat by orotic acid: dose and minimum exposure time required for dietary orotic acid to promote hepatocarcinogenesis. Carcinogenesis. 14(9). 1771–1775. 12 indexed citations
10.
Nelson, J. Stuart, et al.. (1993). The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase. Chemico-Biological Interactions. 89(1). 35–47. 3 indexed citations
12.
Coni, Pierpaolo, Giuseppina Pichiri, Marcello Curto, et al.. (1993). Different Effects of Regenerative and Direct Mitogenic Stimuli on the Growth of Initiated Cells in the Resistant Hepatocyte Model. Japanese Journal of Cancer Research. 84(5). 501–507. 7 indexed citations
13.
Laconi, Ezio, Prema M. Rao, S. Rajalakshmi, P. Pani, & D.S.R. Sarma. (1991). Chronic mitoinhibition during promotion of hepatocarcinogenesis. Digestive Diseases and Sciences. 36(9). 1294–1298. 5 indexed citations
14.
Columbano, Amedeo, Monica Curto, Maria Grazia Ennas, et al.. (1989). Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis. 10(5). 847–850. 26 indexed citations
15.
Roomi, M. Waheed, Amedeo Columbano, Giovanna M. Ledda‐Columbano, & D.S.R. Sarma. (1986). Lead nitrate induces certain biochemical properties characteristic of hepatocyte nodules. Carcinogenesis. 7(10). 1643–1646. 30 indexed citations
16.
Sarma, D.S.R., et al.. (1971). Influence of tryptophan on hepatic polyribosomes and protein synthesis in non-fasted and fasted mice.. Nutrition reports international. 4(1). 1–7. 17 indexed citations
17.
Sidransky, Herschel, Ethel Verney, & D.S.R. Sarma. (1971). Effect of tryptophan on polyribosomes and protein synthesis in liver. American Journal of Clinical Nutrition. 24(7). 779–785. 70 indexed citations
18.
Sarma, D.S.R., et al.. (1968). Species specificity in orotic acid induced fatty liver.. 5. 120–122. 23 indexed citations
19.
Sidransky, Herschel, et al.. (1967). The influence of tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. Biochemical and Biophysical Research Communications. 27(2). 242–248. 70 indexed citations
20.
Sarma, D.S.R., et al.. (1961). Deamidation of nicotinamide and NMN. Biochemical and Biophysical Research Communications. 6(5). 389–393. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026